Basic Information
RNALocate ID: RLID-D:11000084
RNA Symbol: hsa-miR-142-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-142-3p
RNA ID: miRBase:MIMAT0000434
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
Tissue/Cell Line: B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Lymphoma tissue|Mast cells
Database: EVmiRNA
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001786 Endoplasmic reticulum membrane Cortical tissue 32451872
RLID:11001787 Exosome B cell line (Raji)|Primary dendritic cells|T cell line (J77) 21505438
RLID:11001788 Exosome Breast milk 22211110
RLID:11001789 Exosome Serum 22427800
RLID:11001790 Exosome Brain tissue 23382797
RLID:11001791 Exosome Plasma 23663360
RLID:11001792 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001794 Microvesicle Plasma 19951903
RLID:11001795 Microvesicle Liver resident stem cells 20668554
RLID:11001796 Microvesicle Hepatoma cells 23771658
RLID-D:11000362 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-142-3p Mantle cell lymphoma MNDR-E-MI-13915
MNDR hsa-miR-142-3p Splenic marginal zone lymphoma MNDR-E-MI-13916
MNDR hsa-miR-142-3p Multiple sclerosis chronic progressive MNDR-E-MI-13917
MNDR hsa-miR-142-3p Oral squamous cell carcinoma MNDR-E-MI-13918
MNDR hsa-miR-142-3p Medulloblastoma MNDR-E-MI-13919
MNDR hsa-miR-142-3p B cell lymphoma of malt type MNDR-E-MI-13920
MNDR hsa-miR-142-3p Uterine corpus endometrial carcinoma MNDR-E-MI-13921
MNDR hsa-miR-142-3p Lymphoma MNDR-E-MI-13922
MNDR hsa-miR-142-3p Lymphoma non-hodgkin MNDR-E-MI-13923
MNDR hsa-miR-142-3p Estrogen-receptor positive breast cancer MNDR-E-MI-13924
MNDR hsa-miR-142-3p Estrogen-receptor negative breast cancer MNDR-E-MI-13925
MNDR hsa-miR-142-3p Progesterone-receptor positive breast cancer MNDR-E-MI-13926
MNDR hsa-miR-142-3p Progesterone-receptor negative breast cancer MNDR-E-MI-13927
MNDR hsa-miR-142-3p Her2-receptor positive breast cancer MNDR-E-MI-13928
MNDR hsa-miR-142-3p Breast cancer luminal MNDR-E-MI-13929
MNDR hsa-miR-142-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-13930
MNDR hsa-miR-142-3p Dermatomyositis MNDR-E-MI-13931
MNDR hsa-miR-142-3p Prostate cancer MNDR-E-MI-13932
MNDR hsa-miR-142-3p Hirschsprung disease MNDR-E-MI-13933
MNDR hsa-miR-142-3p Gastric cancer MNDR-E-MI-13934
MNDR hsa-miR-142-3p Pre-eclampsia MNDR-E-MI-13935
MNDR hsa-miR-142-3p Alzheimer disease MNDR-E-MI-13936
MNDR hsa-miR-142-3p Sarcoma MNDR-E-MI-13937
MNDR hsa-miR-142-3p Dysautonomia familial MNDR-E-MI-13938
MNDR hsa-miR-142-3p Leukemia MNDR-E-MI-13939
MNDR hsa-miR-142-3p Huntington disease MNDR-E-MI-13940
MNDR hsa-miR-142-3p Chorea MNDR-E-MI-13941
MNDR hsa-miR-142-3p Cardiovascular disease MNDR-E-MI-13942
MNDR hsa-miR-142-3p Moyamoya disease MNDR-E-MI-13943
MNDR hsa-miR-142-3p Lung cancer MNDR-E-MI-13944
MNDR hsa-miR-142-3p Down syndrome MNDR-E-MI-13945
MNDR hsa-miR-142-3p Parkinson disease MNDR-E-MI-13946
MNDR hsa-miR-142-3p Basal-like breast cancer MNDR-E-MI-13947
MNDR hsa-miR-142-3p Thyroid cancer MNDR-E-MI-13948
MNDR hsa-miR-142-3p Pituitary neoplasms MNDR-E-MI-13949
MNDR hsa-miR-142-3p Pancreatic cancer MNDR-E-MI-13950
MNDR hsa-miR-142-3p Melanoma MNDR-E-MI-13951
MNDR hsa-miR-142-3p Rectum adenocarcinoma MNDR-E-MI-13952
MNDR hsa-miR-142-3p Colon cancer MNDR-E-MI-13953
MNDR hsa-miR-142-3p Ischemic attack transient MNDR-E-MI-13954
MNDR hsa-miR-142-3p Colon adenocarcinoma MNDR-E-MI-13955
MNDR hsa-miR-142-3p Multiple sclerosis MNDR-E-MI-13956
MNDR hsa-miR-142-3p Relapsing-remitting multiple sclerosis MNDR-E-MI-13957
MNDR hsa-miR-142-3p Familial ovarian cancer MNDR-E-MI-13958
MNDR hsa-miR-142-3p Asthma MNDR-E-MI-13959
MNDR hsa-miR-142-3p Endometriosis MNDR-E-MI-13960
MNDR hsa-miR-142-3p Carcinoma ductal breast MNDR-E-MI-13961
MNDR hsa-miR-142-3p Glioblastoma MNDR-E-MI-13962
MNDR hsa-miR-142-3p Astrocytoma MNDR-E-MI-13963
MNDR hsa-miR-142-3p Malignant glioma MNDR-E-MI-13964
MNDR hsa-miR-142-3p Amyotrophic lateral sclerosis MNDR-E-MI-13965
MNDR hsa-miR-142-3p Osteosarcoma MNDR-E-MI-13966
MNDR hsa-miR-142-3p Liposarcoma MNDR-E-MI-13967
MNDR hsa-miR-142-3p Breast carcinoma MNDR-E-MI-13968
MNDR hsa-miR-142-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-13969
MNDR hsa-miR-142-3p Meningioma MNDR-E-MI-13970
MNDR hsa-miR-142-3p Uterine cancer MNDR-E-MI-13971
MNDR hsa-miR-142-3p Gastric adenocarcinoma MNDR-E-MI-13972
MNDR hsa-miR-142-3p Cervical squamous cell carcinoma MNDR-E-MI-13973
MNDR hsa-miR-142-3p Pituitary adenoma MNDR-E-MI-13974
MNDR hsa-miR-142-3p Lung squamous cell carcinoma MNDR-E-MI-13975
MNDR hsa-miR-142-3p Carcinoma lung non-small-cell MNDR-E-MI-13976
MNDR hsa-miR-142-3p Lung adenocarcinoma MNDR-E-MI-13977
MNDR hsa-miR-142-3p Thyroid carcinoma MNDR-E-MI-13978
MNDR hsa-miR-142-3p Bladder urothelial carcinoma MNDR-E-MI-13979
MNDR hsa-miR-142-3p Pancreatic adenocarcinoma MNDR-E-MI-13980
MNDR hsa-miR-142-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-13981
MNDR hsa-miR-142-3p Carcinoma renal cell MNDR-E-MI-13982
MNDR hsa-miR-142-3p Kidney renal papillary cell carcinoma MNDR-E-MI-13983
MNDR hsa-miR-142-3p Clear cell renal cell carcinoma MNDR-E-MI-13984
MNDR hsa-miR-142-3p Cholangiocarcinoma MNDR-E-MI-13985
MNDR hsa-miR-142-3p Prolactinoma MNDR-E-MI-13986
MNDR hsa-miR-142-3p Head and neck squamous cell carcinoma MNDR-E-MI-13987
MNDR hsa-miR-142-3p Testicular germ cell cancer MNDR-E-MI-13988
MNDR hsa-miR-142-3p Kidney diseases MNDR-E-MI-13989
MNDR hsa-miR-142-3p T-cell acute lymphoblastic leukemia MNDR-E-MI-13990
MNDR hsa-miR-142-3p Fibromyalgia MNDR-E-MI-13991
MNDR hsa-miR-142-3p Breast invasive carcinoma MNDR-E-MI-13992
MNDR hsa-miR-142-3p Hepatocellular carcinoma MNDR-E-MI-13993
MNDR hsa-miR-142-3p Embryonal cancer MNDR-E-MI-13994
MNDR hsa-miR-142-3p Familiar ovarian carcinoma MNDR-E-MI-13995
MNDR hsa-miR-142-3p B-cell lymphoma MNDR-E-MI-13996
MNDR hsa-miR-142-3p Rheumatoid arthritis MNDR-E-MI-13997
MNDR hsa-miR-142-3p Osteoarthritis MNDR-E-MI-13998
MNDR hsa-miR-142-3p Hodgkin lymphoma MNDR-E-MI-13999
MNDR hsa-miR-142-3p Ulcerative colitis MNDR-E-MI-14000
MNDR hsa-miR-142-3p Burkitt lymphoma MNDR-E-MI-14001
MNDR hsa-miR-142-3p Tonsil cancer MNDR-E-MI-14002
MNDR hsa-miR-142-3p Neuromyelitis optica MNDR-E-MI-14003
MNDR hsa-miR-142-3p Psoriasis MNDR-E-MI-14004
MNDR hsa-miR-142-3p Skin cutaneous melanoma MNDR-E-MI-14005
MNDR hsa-miR-142-3p Skin melanoma MNDR-E-MI-14006
MNDR hsa-miR-142-3p Acute myeloid leukemia MNDR-E-MI-14007
MNDR hsa-miR-142-3p Colorectal cancer MNDR-E-MI-14008
MNDR hsa-miR-142-3p Nasopharyngeal carcinoma MNDR-E-MI-14009
MNDR hsa-miR-142-3p Nasopharynx carcinoma MNDR-E-MI-14010
MNDR hsa-miR-142-3p Multiple myeloma MNDR-E-MI-14011
MNDR hsa-miR-142-3p Acute lymphoblastic leukemia MNDR-E-MI-14012
MNDR hsa-miR-142-3p Ependymoma MNDR-E-MI-14013
MNDR hsa-miR-142-3p Nasopharyngeal cancer MNDR-E-MI-14014
MNDR hsa-miR-142-3p Prostatic neoplasms MNDR-E-MI-14015
MNDR hsa-miR-142-3p Aids dementia complex MNDR-E-MI-14016
MNDR hsa-miR-142-3p Cerebral hemorrhage traumatic MNDR-E-MI-14017
MNDR hsa-miR-142-3p Intracranial hemorrhage hypertensive MNDR-E-MI-14018
MNDR hsa-miR-142-3p Stroke lacunar MNDR-E-MI-14019
MNDR hsa-miR-142-3p Breast cancer her3+ negative MNDR-E-MI-14020
MNDR hsa-miR-142-3p Multiple sclerosis susceptibility MNDR-E-MI-14021
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCG2 Homo sapiens RR00024737
TOP